Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On February 6, 2026, Ernexa Therapeutics Inc., a Delaware corporation (the “Company”), entered into a placement agen
Other Events. The Company issued a press release announcing the pricing of the Offering on February 6, 2026. A copy of the press release is attached hereto as E
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 1.1 Placement Agency Agreement, by and between Ernexa Therapeutics Inc. and Brooklin